EGF and cervical cancer: The above-mentioned evidence based on the molecular investigation in surgical specimens of cervical cancer suggested that the clinical outcome of cancer patients is highly associated with the expression of KCC3, KCC4, and their potent stimulators, IGF-1 and EGF [134,135,137].